Mayo Clinic Researchers Discover Aptamers Target Senescent 'Zombie Cells' for Aging Research
New method uses synthetic DNA molecules to precisely identify cells linked to aging and disease.
Source: Science DailyResearchers at Mayo Clinic have made a significant breakthrough in aging research. They discovered that tiny synthetic DNA molecules, called aptamers, can specifically attach to senescent cells. These 'zombie cells' are known to be linked to aging, cancer, and neurodegenerative diseases. This new method could greatly improve how scientists identify and target these harmful cells in living tissues. The discovery offers a more precise way to study and potentially treat age-related conditions.
- Aptamers are tiny synthetic DNA molecules used in this research.
- They selectively attach to senescent cells, also known as 'zombie cells'.
- Senescent cells are linked to aging, cancer, and neurodegenerative diseases.
- The new method allows for more precise identification and targeting of these cells.
- This breakthrough could lead to better understanding and treatment of age-related conditions.
Aptamers are oligonucleotide or peptide molecules that bind to a specific target molecule. They are often used in biotechnology and medicine for diagnostic and therapeutic purposes, similar to antibodies but with advantages like easier synthesis and stability.
Senescent cells are cells that have stopped dividing but remain metabolically active. They accumulate with age and secrete inflammatory molecules, contributing to aging and age-related diseases like cancer, heart disease, and neurodegeneration.
Mayo Clinic is a non-profit academic medical center focused on integrated patient care, education, and research. It is headquartered in Rochester, Minnesota, and is renowned globally for its medical innovations and patient care.
Exams often test on new scientific discoveries, especially those related to health, aging, and biotechnology. Focus on the key terms like 'aptamers' and 'senescent cells' and their significance.
Remember 'Aptamers' as 'APt' for 'APplying' to 'Target' cells, helping to fight 'Aging' and 'Pathologies'.